In the induction phase, anti-Tim-4 mAb exacerbated the development of CIA, while the arthritis scores and proinflammatory cytokines were reduced in anti-Tim-4 treated mice at effector phase (6). The gene discussed is TIMD4; the disease is Arthritis.